GLP-1 receptor agonist
Semaglutide
A long-acting GLP-1 analog. Authorized products and gray-market powders are not interchangeable.
Semaglutide is discussed because specific prescription products have evidence and authorization for type 2 diabetes, chronic weight management, and certain cardiovascular-risk indications. Those findings belong to the studied products and populations—not to unverified powder sold under the same ingredient name.